SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950103-19-017350
Filing Date
2019-12-18
Accepted
2019-12-18 16:59:41
Documents
1
Period of Report
2019-12-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 dp117771_3.html 3  
1 FORM 3 dp117771_3.xml 3 4968
  Complete submission text file 0000950103-19-017350.txt   7214
Mailing Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070
Business Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070 9732354295
ROCHE HOLDING LTD (Reporting) CIK: 0000889131 (see all company filings)

State of Incorp.: V8
Type: 3 | Act: 34 | File No.: 001-36819 | Film No.: 191293079
SIC: 8880 American Depositary Receipts

Mailing Address 1 DNA WAY, MS #24, SOUTH SAN FRANCISCO CA 94080
Business Address C/O THE CORPORATION TRUST, 1209 ORANGE STREET, WILMINGTON, DE 19801 650 225-7893
ROCHE HOLDINGS INC (Reporting) CIK: 0000904566 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36819 | Film No.: 191293078

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Issuer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)